INFRAFRONTIER open call – Disease model development and systemic phenotyping

17. 01. 2017 Call Information

INFRAFRONTIER, the European Research Infrastructure for phenotyping and archiving of model mammalian genomes is opening a call to facilitate access for the wider biomedical research community to the unique infrastructure and scientific expertise of the INFRAFRONTIER mouse clinics. INFRAFRONTIER offers the testing of mouse mutant lines through a broad based primary phenotyping pipeline in all the major adult organ systems and most areas of major human disease. Access will be granted on the basis of scientific excellence and supports the development and in depth characterisation of new mouse models for investigating gene function and human pathophysiology. INFRAFRONTIER will provide open access to all newly developed disease models and phenotyping data.

More information and call application form:

Proposal submission to by 15 February 2017.

Proposal evaluation from 16 February to 31 March 2017.


Call scope and modalities

  • Applications for the INFRAFRONTIER call can be submitted from scientists across the world. Access will be granted based on scientific excellence and no regional restrictions will apply
  • A total of 15 model development and phenotyping projects will be supported. Access is provided free of charge and on a collaborative basis. The only costs to be borne by the applicants are shipment cost of materials to and from the mouse clinics
  • Participating mouse clinics are Phenomin-ICS, the Czech Centre for Phenogenomics (CCP), and the German Mouse Clinic (GMC)
  • Mouse models can be developed using either genome editing approaches (C57BL/6N genetic background only) or by injecting targeted ES cells of the IKMC resource. Only new mouse models will be developed that are not yet in the production pipelines of the International Mouse Phenotyping Consortium (IMPC, Alternatively, starting materials can also be a breeding nucleus or cohorts ready for phenotyping (acceptance depending on health certificates). In the latter case mouse mutants from various sources (transgenes, knockout mice, mutants from mutagenesis screens like ENU) and of different genetic backgrounds can be accepted
  • The phenotyping pipelines to be used will be either broad based primary phenotyping pipelines with a possible customisation or the adult IMPC phenotype pipeline (
  • Support will be provided by the mouse clinics to analyse and interpret the phenotype data
  • A final report with all phenotype data will be prepared, and data will also be uploaded onto a public phenotype database of the mouse clinics and / or onto the IMPC portal at
  • The generated mouse resources and phenotype data will be made available to the whole scientific community. An optional grace period of up to 1 year for mouse resources and phenotype data may apply, with immediate release of mouse resources and data after expiry of the grace period. Mouse mutant lines will be deposited into the INFRAFRONTIER/EMMA repository for subsequent use by the scientific community